Daniel Silveira
BroadSpan Capital
Milfra
Deal Type
Company sale
Sector
Healthcare
Completion Date
1st June 2021
Deal Value
Not disclosed
Company Background
Milfra is a leading manufacturer of plastic products for the pharmaceutical industry in Brazil, specialized in the development and production of personal care applicators and oral batchers. It has advanced manufacturing capabilities and state-of-the-art industrial plant in Jaguariúna, countryside of São Paulo state, with over 130 employees
Deal Summary
BroadSpan Capital advised Milfra and its shareholders in the sale of 100% of its shares to Nemera.
Based in La Verpillière, France, Nemera is a world-leading drug delivery device solutions provider, including medicine droppers, ointment applicators and electronic devices. The Company had revenues of €430 million in 2020 and operates five industrial plants – two in France and one each in the United States, Germany and Poland.
This strategic acquisition expands Nemera’s global footprint in Latin America, extends its product offering and provides a foundation for future contract manufacturing services. By integrating a key applicator pure player, Nemera will now be able to address specific patient and customer needs in the fields of gynecology and urology in Brazil.
On June 15th, 2021, Milfra’s shareholders completed a transaction involving the sale of 100% of their equity interest to Nemera.
Value Added
BroadSpan actively served Milfra’s shareholders in this transaction in order to maximize its value and diminish its risks and guarantees
Latest Mergers Alliance News
Khronos Advisory (Thailand) has advised Electricity Generating Public Company Limited (EGCO) on USD95 million capital increase in PT Chandra Daya Investasi
Dresner Partners (USA) advised Connoisseurs Products on its sale to Willert Home Products
Ethica Group (Italy) advised Vicenza Mode, high-end knitwear manufacturer, in the sale of a majority stake to Sienna PE
